ReWalk Robotics - RWLK Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ReWalk Robotics in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RWLK shares.
View RWLK analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 1-year price targets for ReWalk Robotics' stock. Their RWLK share price forecasts range from $2.50 to $2.50. On average, they anticipate the company's share price to reach $2.50 in the next twelve months. This suggests a possible upside of 189.4% from the stock's current price.
View analysts price targets for RWLK or view top-rated stocks among Wall Street analysts.

ReWalk Robotics' stock was trading at $1.23 at the beginning of 2022. Since then, RWLK stock has decreased by 29.8% and is now trading at $0.8639.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our RWLK earnings forecast.

ReWalk Robotics Ltd. (NASDAQ:RWLK) released its quarterly earnings results on Tuesday, August, 9th. The medical device company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.03. The medical device company earned $1.57 million during the quarter, compared to the consensus estimate of $2.32 million. ReWalk Robotics had a negative net margin of 270.83% and a negative trailing twelve-month return on equity of 17.60%. During the same period in the previous year, the firm earned ($0.07) earnings per share.

Based on aggregate information from My MarketBeat watchlists, some companies that other ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), BlackRock Capital Investment (BKCC), NovoCure (NVCR), Viper Energy Partners (VNOM), Summit Midstream Partners (SMLP), Washington Prime Group (WPG) and Roper Technologies (ROP).

ReWalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

ReWalk Robotics' stock is owned by many different institutional and retail investors. Top institutional investors include Millennium Management LLC (0.22%), Renaissance Technologies LLC (0.15%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Global Fund Lp Lind II, Jeff Dykan and Lawrence J Jasinski.
View institutional ownership trends.

Shares of RWLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of RWLK stock can currently be purchased for approximately $0.86.

ReWalk Robotics (NASDAQ:RWLK) has a market capitalization of $54.06 million and generates $5.97 million in revenue each year. The medical device company earns $-12,740,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis.

ReWalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The official website for the company is www.rewalk.com. The medical device company can be reached via phone at (724) 959-0123 or via email at ir@rewalk.com.